Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
 
Register | Sign in
Home Page>Products
  Product News
Improving the Consistency & Efficiency of Early Drug Discovery
Wednesday, October 15, 2014
Consistency and efficiency of assays improved by using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA.

IDT Launches Modular NGS Gene Capture Pools
Wednesday, October 15, 2014
Easy access to customizable and cost-effective target capture.

Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

New Compact SIMS to Launch at Vacuum Expo 2014
Tuesday, October 14, 2014
Designed for fast and easy characterization of layer structures, surface contamination and impurities of positive ions.

New Analog Hot Plates & Stirrers
Tuesday, October 14, 2014
New line of multi-position stirring hot plates and stirrers features 5 or 9 stirring positions.

Bioo Scientific Offers Complete Line of Sensitive Kits for Quinolone Residue Detection
Tuesday, October 14, 2014
Bioo Scientific offers MaxSignal® Difloxacin, Ofloxacin, Sarafloxacin and Oxolinic Acid ELISA Test Kit.

Diatron Launches Intelligent Walk-away Analyzer at Medica
Monday, October 13, 2014
The P500 offers cost-effective bench top automation for clinical chemistry.

New Additions to Malvern Instruments’ ‘10 ways to…’ Whitepaper Series
Saturday, October 11, 2014
Two new additions to whitepaper series guide rheological optimization of dispersion products.

DNASTAR Releases Lasergene 12.1 Software
Saturday, October 11, 2014
Lasergene 12.1 integrates cloud capability with ground computers.

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 10671
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv